Medication Guide - 2/16/2022

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Application Number Application Type Supplement Date Database Updated BRAFTOVI ENCORAFENIB 210496 NDA 02/11/2022 02/15/2022 PROCYSBI CYSTEAMINE BITARTRATE 203389 NDA 02/11/2022 02/15/2022 PROCYSBI CYSTEAMINE BITARTRATE 213491 NDA 02/11/2022 02/15/2022 TECFIDERA DIMETHYL FUMARATE 204063 NDA 02/10/2022 02/15/2022 VUMERITY DIROXIMEL FUMARATE 211855 NDA 02/10/2022 02/14/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA